Product
Isavuconazonium
Aliases
Cresemba, Cresemba®, Isavuconazonium sulfate
2 clinical trials
3 indications
Indication
MucormycosisIndication
Invasive AspergillosisIndication
Hematological MalignancyClinical trial
A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric SubjectsStatus: Completed, Estimated PCD: 2022-12-14
Clinical trial
A Phase 1, Open-label, Multicenter, Non-comparative Pharmacokinetics and Safety Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsStatus: Completed, Estimated PCD: 2019-07-05